Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (674)	9/2/1999 9:02:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 4474

I gave up trying to count...I had something like all flavors totals up to ~30M. LaMarche seemed okay with that number when I ran it by him. Don't know why he was so annoyed with me, as I pointed out somewhere on the thread, it's not me selling shares. I suspect that somewhere, on either this thread or over on Yahoo, one of my many posts had some truth in it. Now if I only knew what message pushed his button. Have to give them credit, completely tight lipped--but it may be that I am simply not clever enough to know what questions to ask--I voiced my displeasure over the converts, but I should have been trying to snag some hints about what is going on in the lab right now. Still waiting for a mid-year report. Suspect it is delayed because everybody is tied up negotiating with potential ARGENT partners...sure hope that is it. Once a week I check the BBRS database for updates, ARIA still rated a buy. If that gets knocked down, I am so screwed. With an ARGENT parner, I would guess Bancboston will take it up to strong buy, now that would be nice.

To: LLCF who wrote (674)	9/3/1999 7:39:00 AM
From: Dr. John M. de Castro	Read Replies (1) \| Respond to of 4474

DAK, my understanding is that there a 5,000 toxics out there and that they have not yet been converted. There were some stipulations regarding the second tranch which I believe ARIA has not yet been able to meet. It's kinda scarry to think that this company isn't even able to meet the stipulations of a floorless convertible. I'd appreciate corrections if my interpretation is incorrect. In regard to dillution, until these toxics are converted we will not see there dillutive effects. At current levels the toxics could convert into about 7MM shares. If the stock goes lower, say to 1/2, then that number goes up to nearly 12MM shares. Best regards John de C